aCardiovascular Department, AO 'Ospedale Civile', Legnano bDivision of Cardiology, Manzoni Hospital, Lecco cDivision of Cardiology, Misericordia e Dolce Hospital, Prato dDivision of Cardiology, AO 'Villa Scassi', Genova eDivision of Cardiology, Ospedali Riuniti, Treviglio fCardiology Unit, Spedali Civili, Brescia gDivision of Cardiology, St Antonio Abate Hospital, Gallarate hDivision of Cardiology, Desio Hospital, Desio iDivision of Cardiology, Terni Hospital, Terni jLaboratory Unit, AO 'Ospedale Civile' di Legnano, Italy.
J Cardiovasc Med (Hagerstown). 2014 Jan;15(1):42-7. doi: 10.2459/JCM.0b013e328365a275.
Serum cystatin C (Cys-C), a good marker of renal function, predicts prognosis in non-ST-elevation acute coronary syndromes (NSTE-ACS). However, no data are available on the time course of Cys-C values after discharge. In this study, Cys-C was measured during admission (ACS sample) and 6 weeks after discharge, and was correlated with troponin (c-TNT), high-sensitivity C-reactive protein (hsCRP), interleukin 6 (IL-6) and the N-terminal portion of the pro-brain natriuretic peptide (proBNP) peptide (NT-proBNP) in a highly selected homogeneous group of NSTE-ACS patients.
In this prospective, multicentre study, patients with a first NSTE-ACS, single-vessel disease and successful percutaneous coronary interventions (PCIs) had their sera collected, aliquoted and stored at the enrolling site and then shipped for analysis to the clinical chemistry core laboratory.
Cys-C values slightly, but significantly, increased from the ACS samples to the 6-week samples. In contrast, hsCRP, NT-proBNP and IL-6 values significantly decreased from the ACS to the 6-week sample. Patients with elevated c-TNT levels had higher hsCRP, NT-proBNP and IL-6 values than patients with normal c-TNT levels in the ACS sample, whereas Cys-C levels were similar in patients with and without elevated c-TNT. Cys-C was highly correlated with estimated glomerular filtration rate in both the ACS and 6-week samples.
In contrast to inflammatory and biochemical stress markers, Cys-C is not affected by the occurrence of myocardial necrosis or by acute left-ventricular impairment, being a reliable marker of renal function during NSTE-ACS.
血清胱抑素 C(Cys-C)是肾功能的良好标志物,可预测非 ST 段抬高型急性冠状动脉综合征(NSTE-ACS)的预后。然而,目前尚无关于出院后 Cys-C 值时间进程的相关数据。在本研究中,我们在入院时(ACS 样本)和出院后 6 周时测量了 Cys-C 值,并将其与肌钙蛋白(c-TNT)、高敏 C 反应蛋白(hsCRP)、白细胞介素 6(IL-6)和脑钠肽前体(proBNP)的 N 末端片段(NT-proBNP)在高度选择的 NSTE-ACS 患者同质组中进行了相关性分析。
在这项前瞻性、多中心研究中,我们收集了首次发生 NSTE-ACS、单支血管病变且经皮冠状动脉介入治疗(PCI)成功的患者的血清,分装并储存在入组地点,然后运送到临床化学核心实验室进行分析。
与 ACS 样本相比,Cys-C 值略有但显著升高至 6 周样本。相反,hsCRP、NT-proBNP 和 IL-6 值从 ACS 样本显著降低至 6 周样本。与 c-TNT 水平正常的患者相比,c-TNT 水平升高的患者在 ACS 样本中具有更高的 hsCRP、NT-proBNP 和 IL-6 值,而 Cys-C 值在 c-TNT 水平升高和正常的患者中相似。Cys-C 值与 ACS 和 6 周样本中的估算肾小球滤过率高度相关。
与炎症和生化应激标志物不同,Cys-C 不受心肌坏死或急性左心室功能障碍的影响,是 NSTE-ACS 期间肾功能的可靠标志物。